Symax SL (Page 2 of 2)

DOSAGE AND ADMINISTRATION

Dosage may be adjusted according to the condition and severity of symptoms. May be taken with or without water.

Adults and adolescents 12 years and older: Oral or sublingual, 1 to 2 tablets three or four times a day, thirty minutes to one hour before meals and at bedtime. Dosage may be increased to every four hours as needed. Do not exceed 12 tablets in 24 hours.

Note: Geriatric patients may be more sensitive to the effects of the usual adult dose.

HOW SUPPLIED

Symax ® -SL is supplied as green, round, sublingual, peppermint flavored tablets debossed “SL” over “125”. Available in bottles of 100 tablets, NDC 64543-111-01.

Storage and Handling

Dispense in a tight, light-resistant container as defined in USP/NF, with a child-resistant closure. Store at controlled room temperature between 20°-25°C (68°- 77°F), see USP Controlled Room Temperature.

KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.

Manufactured for:
Capellon Pharmaceuticals, LLC
Ft. Worth, TX 76118

Rx Only

Rev. 06/2014

500010-02

PRINCIPAL DISPLAY PANEL

figure-02
(click image for full-size original)
SYMAX SL
hyoscyamine sulfate tablet, orally disintegrating
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:64543-111
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
HYOSCYAMINE SULFATE (HYOSCYAMINE) HYOSCYAMINE SULFATE 0.125 mg
Inactive Ingredients
Ingredient Name Strength
D&C YELLOW NO. 10
FD&C BLUE NO. 1
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
MANNITOL
STARCH, CORN
STEARIC ACID
Product Characteristics
Color green Score no score
Shape ROUND Size 6mm
Flavor PEPPERMINT Imprint Code SL;125
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:64543-111-01 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 09/01/1996
Labeler — Capellon Pharmaceuticals, LLC (124568093)

Revised: 09/2021 Capellon Pharmaceuticals, LLC

Page 2 of 2 1 2

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.